Seon-Wook Hwang

Chief Executive Officer at NOVMETAPHARMA CO., LTD.

Net worth: 17 M $ as of 2023-07-30

64 year

Health Technology

Consumer Services

Profile

Seon-Wook Hwang is currently the President, Co-Chief Executive Officer & Director at NovMetaPharma Co., Ltd.
He is also the Chief Executive Officer at PNC Holdings Co. Ltd.
and NovMetaHealth Co. Ltd.
Mr. Hwang completed his undergraduate and graduate degrees at Chung-Ang University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
NOVMETAPHARMA CO., LTD. 9.36%	2023-06-29	1,038,030 ( 9.36% )	17 M $	2023-07-30

Seon-Wook Hwang active positions

Companies	Position	Start
NOVMETAPHARMA CO., LTD.	Chief Executive Officer	2010-11-03
NovMetaHealth Co. Ltd. NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million.	Chief Executive Officer	2016-02-29
PNC Holdings Co. Ltd.	Chief Executive Officer	2015-08-31

All active positions of Seon-Wook Hwang

Training of Seon-Wook Hwang

Chung-Ang University

Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Seon-Wook Hwang's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
NOVMETAPHARMA CO., LTD.	Health Technology

Private companies	2
NovMetaHealth Co. Ltd. NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million.	Health Technology
PNC Holdings Co. Ltd.